Live news related to MAAT PHARMA stock (FR0012634822): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
MaaT Pharma has announced the receipt of funds to support its clinical development programs, following recent agreements with the European Investment …
MaaT Pharma revealed preclinical results for its drug candidate MaaT034 at the annual congress of the Society for Immunotherapy of Cancer (SITC), acco…
MaaT Pharma announced that the results of its Phase 3 study on the Xervyteg treatment will be presented at the ASH 2025 annual congress.
